Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (5407)	2/11/1998 12:25:00 AM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

TA I expect a pe of 20+ in 99 and with projected earnings of $3.49......... that's $70+ per share in 99. The problem is that analyst are too focused on the current qtr's earnings ...when will MCA approval occur...when will FDA certify the new plant.....these are short term issues....look at the longer view. All these issues will be resolved in the first half of 98... 1999 will have explosive earnings... This is a great time to buy VVUS... As soon as the MCA and FDA issues are behind us analyst will revise the current year eps and this stock will take off....however the price will be well above 20 before some analyst will publish their upgrades.

To: Tunica Albuginea who wrote (5407)	2/11/1998 6:58:00 AM
From: blankmind	Read Replies (1) \| Respond to of 23519

- I'm not really surprised about Zacks - but like Prez Reagan would say - trust but verify. So I went over to Zacks, and saw: "Consensus Estimate for Next Fiscal Year ( 12/99 ) $ 3.49 per share" - There's even one analyst with a "Strong Buy" - that the highest rating. - Plus, analysts are estimating a loss of 4 cents for this quarter. And with all of the advertising and new plant costs, who knows, Vivus may really post a loss. But then again, if approval received this month or early FEb, and all that product gets snatched up by Astra and sold in Europe & beyone, and who knows? - Bottom line: I'm not surprsed by the $3.49 earnings projection. In fact, after the Dec '97 confer call, several posters, including myself, said Vivus could do $3 or $4 a share. VVUS stock was at $10. And folks said it was crazy. As we get closer to new plant approval, it's seeming more achievable. Out.